Global Molecular Pharming Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Molecular Pharming market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molecular Pharming players cover Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech and Core Biogenesis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
LPI (LP Information)' newest research report, the “Molecular Pharming Industry Forecast” looks at past sales and reviews total world Molecular Pharming sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Pharming sales for 2023 through 2029. With Molecular Pharming sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Pharming industry.
This Insight Report provides a comprehensive analysis of the global Molecular Pharming landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Pharming portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Pharming market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Pharming and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Pharming.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Pharming market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Molecular Pharming market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molecular Pharming is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molecular Pharming players cover Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech and Core Biogenesis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
LPI (LP Information)' newest research report, the “Molecular Pharming Industry Forecast” looks at past sales and reviews total world Molecular Pharming sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Pharming sales for 2023 through 2029. With Molecular Pharming sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Pharming industry.
This Insight Report provides a comprehensive analysis of the global Molecular Pharming landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Pharming portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Pharming market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Pharming and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Pharming.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Pharming market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Gene Gun
- Agroinfiltration
- Electroporation
- Agrobacterium-Mediated Gene Transfer
- Recombinant Antibodies
- Hormones, Vaccines
- Industrial Enzymes
- Proteins & Protein-Based Materials
- Technical Reagents
- Nutritional Products
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medicago Inc
- Meristem Therapeutics S.A. (Ventria Bioscience)
- Miruku
- Moolec Science Limited
- mozza
- Nobell Foods
- Agrenvec S.L
- Bright Biotech
- Core Biogenesis
- Diamante SRL
- Leaf Systems International Limited
- ORF Genetics
- Pfizer, Inc.
- ProdiGene Inc
- Protalix Biotherapeutics, Inc
- Tiamat Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Pharming Market Size 2018-2029
2.1.2 Molecular Pharming Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Molecular Pharming Segment by Type
2.2.1 Gene Gun
2.2.2 Agroinfiltration
2.2.3 Electroporation
2.2.4 Agrobacterium-Mediated Gene Transfer
2.3 Molecular Pharming Market Size by Type
2.3.1 Molecular Pharming Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Molecular Pharming Market Size Market Share by Type (2018-2023)
2.4 Molecular Pharming Segment by Application
2.4.1 Recombinant Antibodies
2.4.2 Hormones, Vaccines
2.4.3 Industrial Enzymes
2.4.4 Proteins & Protein-Based Materials
2.4.5 Technical Reagents
2.4.6 Nutritional Products
2.5 Molecular Pharming Market Size by Application
2.5.1 Molecular Pharming Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Molecular Pharming Market Size Market Share by Application (2018-2023)
3 MOLECULAR PHARMING MARKET SIZE BY PLAYER
3.1 Molecular Pharming Market Size Market Share by Players
3.1.1 Global Molecular Pharming Revenue by Players (2018-2023)
3.1.2 Global Molecular Pharming Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Pharming Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR PHARMING BY REGIONS
4.1 Molecular Pharming Market Size by Regions (2018-2023)
4.2 Americas Molecular Pharming Market Size Growth (2018-2023)
4.3 APAC Molecular Pharming Market Size Growth (2018-2023)
4.4 Europe Molecular Pharming Market Size Growth (2018-2023)
4.5 Middle East & Africa Molecular Pharming Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Molecular Pharming Market Size by Country (2018-2023)
5.2 Americas Molecular Pharming Market Size by Type (2018-2023)
5.3 Americas Molecular Pharming Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Pharming Market Size by Region (2018-2023)
6.2 APAC Molecular Pharming Market Size by Type (2018-2023)
6.3 APAC Molecular Pharming Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Pharming by Country (2018-2023)
7.2 Europe Molecular Pharming Market Size by Type (2018-2023)
7.3 Europe Molecular Pharming Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Pharming by Region (2018-2023)
8.2 Middle East & Africa Molecular Pharming Market Size by Type (2018-2023)
8.3 Middle East & Africa Molecular Pharming Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR PHARMING MARKET FORECAST
10.1 Global Molecular Pharming Forecast by Regions (2024-2029)
10.1.1 Global Molecular Pharming Forecast by Regions (2024-2029)
10.1.2 Americas Molecular Pharming Forecast
10.1.3 APAC Molecular Pharming Forecast
10.1.4 Europe Molecular Pharming Forecast
10.1.5 Middle East & Africa Molecular Pharming Forecast
10.2 Americas Molecular Pharming Forecast by Country (2024-2029)
10.2.1 United States Molecular Pharming Market Forecast
10.2.2 Canada Molecular Pharming Market Forecast
10.2.3 Mexico Molecular Pharming Market Forecast
10.2.4 Brazil Molecular Pharming Market Forecast
10.3 APAC Molecular Pharming Forecast by Region (2024-2029)
10.3.1 China Molecular Pharming Market Forecast
10.3.2 Japan Molecular Pharming Market Forecast
10.3.3 Korea Molecular Pharming Market Forecast
10.3.4 Southeast Asia Molecular Pharming Market Forecast
10.3.5 India Molecular Pharming Market Forecast
10.3.6 Australia Molecular Pharming Market Forecast
10.4 Europe Molecular Pharming Forecast by Country (2024-2029)
10.4.1 Germany Molecular Pharming Market Forecast
10.4.2 France Molecular Pharming Market Forecast
10.4.3 UK Molecular Pharming Market Forecast
10.4.4 Italy Molecular Pharming Market Forecast
10.4.5 Russia Molecular Pharming Market Forecast
10.5 Middle East & Africa Molecular Pharming Forecast by Region (2024-2029)
10.5.1 Egypt Molecular Pharming Market Forecast
10.5.2 South Africa Molecular Pharming Market Forecast
10.5.3 Israel Molecular Pharming Market Forecast
10.5.4 Turkey Molecular Pharming Market Forecast
10.5.5 GCC Countries Molecular Pharming Market Forecast
10.6 Global Molecular Pharming Forecast by Type (2024-2029)
10.7 Global Molecular Pharming Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Medicago Inc
11.1.1 Medicago Inc Company Information
11.1.2 Medicago Inc Molecular Pharming Product Offered
11.1.3 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Medicago Inc Main Business Overview
11.1.5 Medicago Inc Latest Developments
11.2 Meristem Therapeutics S.A. (Ventria Bioscience)
11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Information
11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product Offered
11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Main Business Overview
11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Latest Developments
11.3 Miruku
11.3.1 Miruku Company Information
11.3.2 Miruku Molecular Pharming Product Offered
11.3.3 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Miruku Main Business Overview
11.3.5 Miruku Latest Developments
11.4 Moolec Science Limited
11.4.1 Moolec Science Limited Company Information
11.4.2 Moolec Science Limited Molecular Pharming Product Offered
11.4.3 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Moolec Science Limited Main Business Overview
11.4.5 Moolec Science Limited Latest Developments
11.5 mozza
11.5.1 mozza Company Information
11.5.2 mozza Molecular Pharming Product Offered
11.5.3 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 mozza Main Business Overview
11.5.5 mozza Latest Developments
11.6 Nobell Foods
11.6.1 Nobell Foods Company Information
11.6.2 Nobell Foods Molecular Pharming Product Offered
11.6.3 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Nobell Foods Main Business Overview
11.6.5 Nobell Foods Latest Developments
11.7 Agrenvec S.L
11.7.1 Agrenvec S.L Company Information
11.7.2 Agrenvec S.L Molecular Pharming Product Offered
11.7.3 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Agrenvec S.L Main Business Overview
11.7.5 Agrenvec S.L Latest Developments
11.8 Bright Biotech
11.8.1 Bright Biotech Company Information
11.8.2 Bright Biotech Molecular Pharming Product Offered
11.8.3 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bright Biotech Main Business Overview
11.8.5 Bright Biotech Latest Developments
11.9 Core Biogenesis
11.9.1 Core Biogenesis Company Information
11.9.2 Core Biogenesis Molecular Pharming Product Offered
11.9.3 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Core Biogenesis Main Business Overview
11.9.5 Core Biogenesis Latest Developments
11.10 Diamante SRL
11.10.1 Diamante SRL Company Information
11.10.2 Diamante SRL Molecular Pharming Product Offered
11.10.3 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Diamante SRL Main Business Overview
11.10.5 Diamante SRL Latest Developments
11.11 Leaf Systems International Limited
11.11.1 Leaf Systems International Limited Company Information
11.11.2 Leaf Systems International Limited Molecular Pharming Product Offered
11.11.3 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Leaf Systems International Limited Main Business Overview
11.11.5 Leaf Systems International Limited Latest Developments
11.12 ORF Genetics
11.12.1 ORF Genetics Company Information
11.12.2 ORF Genetics Molecular Pharming Product Offered
11.12.3 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ORF Genetics Main Business Overview
11.12.5 ORF Genetics Latest Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Information
11.13.2 Pfizer, Inc. Molecular Pharming Product Offered
11.13.3 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Pfizer, Inc. Main Business Overview
11.13.5 Pfizer, Inc. Latest Developments
11.14 ProdiGene Inc
11.14.1 ProdiGene Inc Company Information
11.14.2 ProdiGene Inc Molecular Pharming Product Offered
11.14.3 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ProdiGene Inc Main Business Overview
11.14.5 ProdiGene Inc Latest Developments
11.15 Protalix Biotherapeutics, Inc
11.15.1 Protalix Biotherapeutics, Inc Company Information
11.15.2 Protalix Biotherapeutics, Inc Molecular Pharming Product Offered
11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Protalix Biotherapeutics, Inc Main Business Overview
11.15.5 Protalix Biotherapeutics, Inc Latest Developments
11.16 Tiamat Sciences
11.16.1 Tiamat Sciences Company Information
11.16.2 Tiamat Sciences Molecular Pharming Product Offered
11.16.3 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Tiamat Sciences Main Business Overview
11.16.5 Tiamat Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Pharming Market Size 2018-2029
2.1.2 Molecular Pharming Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Molecular Pharming Segment by Type
2.2.1 Gene Gun
2.2.2 Agroinfiltration
2.2.3 Electroporation
2.2.4 Agrobacterium-Mediated Gene Transfer
2.3 Molecular Pharming Market Size by Type
2.3.1 Molecular Pharming Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Molecular Pharming Market Size Market Share by Type (2018-2023)
2.4 Molecular Pharming Segment by Application
2.4.1 Recombinant Antibodies
2.4.2 Hormones, Vaccines
2.4.3 Industrial Enzymes
2.4.4 Proteins & Protein-Based Materials
2.4.5 Technical Reagents
2.4.6 Nutritional Products
2.5 Molecular Pharming Market Size by Application
2.5.1 Molecular Pharming Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Molecular Pharming Market Size Market Share by Application (2018-2023)
3 MOLECULAR PHARMING MARKET SIZE BY PLAYER
3.1 Molecular Pharming Market Size Market Share by Players
3.1.1 Global Molecular Pharming Revenue by Players (2018-2023)
3.1.2 Global Molecular Pharming Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Pharming Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR PHARMING BY REGIONS
4.1 Molecular Pharming Market Size by Regions (2018-2023)
4.2 Americas Molecular Pharming Market Size Growth (2018-2023)
4.3 APAC Molecular Pharming Market Size Growth (2018-2023)
4.4 Europe Molecular Pharming Market Size Growth (2018-2023)
4.5 Middle East & Africa Molecular Pharming Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Molecular Pharming Market Size by Country (2018-2023)
5.2 Americas Molecular Pharming Market Size by Type (2018-2023)
5.3 Americas Molecular Pharming Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Pharming Market Size by Region (2018-2023)
6.2 APAC Molecular Pharming Market Size by Type (2018-2023)
6.3 APAC Molecular Pharming Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Pharming by Country (2018-2023)
7.2 Europe Molecular Pharming Market Size by Type (2018-2023)
7.3 Europe Molecular Pharming Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Pharming by Region (2018-2023)
8.2 Middle East & Africa Molecular Pharming Market Size by Type (2018-2023)
8.3 Middle East & Africa Molecular Pharming Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR PHARMING MARKET FORECAST
10.1 Global Molecular Pharming Forecast by Regions (2024-2029)
10.1.1 Global Molecular Pharming Forecast by Regions (2024-2029)
10.1.2 Americas Molecular Pharming Forecast
10.1.3 APAC Molecular Pharming Forecast
10.1.4 Europe Molecular Pharming Forecast
10.1.5 Middle East & Africa Molecular Pharming Forecast
10.2 Americas Molecular Pharming Forecast by Country (2024-2029)
10.2.1 United States Molecular Pharming Market Forecast
10.2.2 Canada Molecular Pharming Market Forecast
10.2.3 Mexico Molecular Pharming Market Forecast
10.2.4 Brazil Molecular Pharming Market Forecast
10.3 APAC Molecular Pharming Forecast by Region (2024-2029)
10.3.1 China Molecular Pharming Market Forecast
10.3.2 Japan Molecular Pharming Market Forecast
10.3.3 Korea Molecular Pharming Market Forecast
10.3.4 Southeast Asia Molecular Pharming Market Forecast
10.3.5 India Molecular Pharming Market Forecast
10.3.6 Australia Molecular Pharming Market Forecast
10.4 Europe Molecular Pharming Forecast by Country (2024-2029)
10.4.1 Germany Molecular Pharming Market Forecast
10.4.2 France Molecular Pharming Market Forecast
10.4.3 UK Molecular Pharming Market Forecast
10.4.4 Italy Molecular Pharming Market Forecast
10.4.5 Russia Molecular Pharming Market Forecast
10.5 Middle East & Africa Molecular Pharming Forecast by Region (2024-2029)
10.5.1 Egypt Molecular Pharming Market Forecast
10.5.2 South Africa Molecular Pharming Market Forecast
10.5.3 Israel Molecular Pharming Market Forecast
10.5.4 Turkey Molecular Pharming Market Forecast
10.5.5 GCC Countries Molecular Pharming Market Forecast
10.6 Global Molecular Pharming Forecast by Type (2024-2029)
10.7 Global Molecular Pharming Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Medicago Inc
11.1.1 Medicago Inc Company Information
11.1.2 Medicago Inc Molecular Pharming Product Offered
11.1.3 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Medicago Inc Main Business Overview
11.1.5 Medicago Inc Latest Developments
11.2 Meristem Therapeutics S.A. (Ventria Bioscience)
11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Information
11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product Offered
11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Main Business Overview
11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Latest Developments
11.3 Miruku
11.3.1 Miruku Company Information
11.3.2 Miruku Molecular Pharming Product Offered
11.3.3 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Miruku Main Business Overview
11.3.5 Miruku Latest Developments
11.4 Moolec Science Limited
11.4.1 Moolec Science Limited Company Information
11.4.2 Moolec Science Limited Molecular Pharming Product Offered
11.4.3 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Moolec Science Limited Main Business Overview
11.4.5 Moolec Science Limited Latest Developments
11.5 mozza
11.5.1 mozza Company Information
11.5.2 mozza Molecular Pharming Product Offered
11.5.3 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 mozza Main Business Overview
11.5.5 mozza Latest Developments
11.6 Nobell Foods
11.6.1 Nobell Foods Company Information
11.6.2 Nobell Foods Molecular Pharming Product Offered
11.6.3 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Nobell Foods Main Business Overview
11.6.5 Nobell Foods Latest Developments
11.7 Agrenvec S.L
11.7.1 Agrenvec S.L Company Information
11.7.2 Agrenvec S.L Molecular Pharming Product Offered
11.7.3 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Agrenvec S.L Main Business Overview
11.7.5 Agrenvec S.L Latest Developments
11.8 Bright Biotech
11.8.1 Bright Biotech Company Information
11.8.2 Bright Biotech Molecular Pharming Product Offered
11.8.3 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bright Biotech Main Business Overview
11.8.5 Bright Biotech Latest Developments
11.9 Core Biogenesis
11.9.1 Core Biogenesis Company Information
11.9.2 Core Biogenesis Molecular Pharming Product Offered
11.9.3 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Core Biogenesis Main Business Overview
11.9.5 Core Biogenesis Latest Developments
11.10 Diamante SRL
11.10.1 Diamante SRL Company Information
11.10.2 Diamante SRL Molecular Pharming Product Offered
11.10.3 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Diamante SRL Main Business Overview
11.10.5 Diamante SRL Latest Developments
11.11 Leaf Systems International Limited
11.11.1 Leaf Systems International Limited Company Information
11.11.2 Leaf Systems International Limited Molecular Pharming Product Offered
11.11.3 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Leaf Systems International Limited Main Business Overview
11.11.5 Leaf Systems International Limited Latest Developments
11.12 ORF Genetics
11.12.1 ORF Genetics Company Information
11.12.2 ORF Genetics Molecular Pharming Product Offered
11.12.3 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ORF Genetics Main Business Overview
11.12.5 ORF Genetics Latest Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Information
11.13.2 Pfizer, Inc. Molecular Pharming Product Offered
11.13.3 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Pfizer, Inc. Main Business Overview
11.13.5 Pfizer, Inc. Latest Developments
11.14 ProdiGene Inc
11.14.1 ProdiGene Inc Company Information
11.14.2 ProdiGene Inc Molecular Pharming Product Offered
11.14.3 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ProdiGene Inc Main Business Overview
11.14.5 ProdiGene Inc Latest Developments
11.15 Protalix Biotherapeutics, Inc
11.15.1 Protalix Biotherapeutics, Inc Company Information
11.15.2 Protalix Biotherapeutics, Inc Molecular Pharming Product Offered
11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Protalix Biotherapeutics, Inc Main Business Overview
11.15.5 Protalix Biotherapeutics, Inc Latest Developments
11.16 Tiamat Sciences
11.16.1 Tiamat Sciences Company Information
11.16.2 Tiamat Sciences Molecular Pharming Product Offered
11.16.3 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Tiamat Sciences Main Business Overview
11.16.5 Tiamat Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Pharming Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Gene Gun
Table 3. Major Players of Agroinfiltration
Table 4. Major Players of Electroporation
Table 5. Major Players of Agrobacterium-Mediated Gene Transfer
Table 6. Molecular Pharming Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 9. Molecular Pharming Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 12. Global Molecular Pharming Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Molecular Pharming Revenue Market Share by Player (2018-2023)
Table 14. Molecular Pharming Key Players Head office and Products Offered
Table 15. Molecular Pharming Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Pharming Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Molecular Pharming Market Size Market Share by Regions (2018-2023)
Table 20. Global Molecular Pharming Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Molecular Pharming Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Molecular Pharming Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Molecular Pharming Market Size Market Share by Country (2018-2023)
Table 24. Americas Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 26. Americas Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 28. APAC Molecular Pharming Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Molecular Pharming Market Size Market Share by Region (2018-2023)
Table 30. APAC Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 32. APAC Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 34. Europe Molecular Pharming Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Molecular Pharming Market Size Market Share by Country (2018-2023)
Table 36. Europe Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 38. Europe Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Molecular Pharming Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Molecular Pharming Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Molecular Pharming
Table 47. Key Market Challenges & Risks of Molecular Pharming
Table 48. Key Industry Trends of Molecular Pharming
Table 49. Global Molecular Pharming Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Molecular Pharming Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Molecular Pharming Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Molecular Pharming Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Medicago Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 54. Medicago Inc Molecular Pharming Product Offered
Table 55. Medicago Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Medicago Inc Main Business
Table 57. Medicago Inc Latest Developments
Table 58. Meristem Therapeutics S.A. (Ventria Bioscience) Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 59. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product Offered
Table 60. Meristem Therapeutics S.A. (Ventria Bioscience) Main Business
Table 61. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Meristem Therapeutics S.A. (Ventria Bioscience) Latest Developments
Table 63. Miruku Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 64. Miruku Molecular Pharming Product Offered
Table 65. Miruku Main Business
Table 66. Miruku Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Miruku Latest Developments
Table 68. Moolec Science Limited Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 69. Moolec Science Limited Molecular Pharming Product Offered
Table 70. Moolec Science Limited Main Business
Table 71. Moolec Science Limited Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Moolec Science Limited Latest Developments
Table 73. mozza Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 74. mozza Molecular Pharming Product Offered
Table 75. mozza Main Business
Table 76. mozza Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. mozza Latest Developments
Table 78. Nobell Foods Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 79. Nobell Foods Molecular Pharming Product Offered
Table 80. Nobell Foods Main Business
Table 81. Nobell Foods Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Nobell Foods Latest Developments
Table 83. Agrenvec S.L Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 84. Agrenvec S.L Molecular Pharming Product Offered
Table 85. Agrenvec S.L Main Business
Table 86. Agrenvec S.L Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Agrenvec S.L Latest Developments
Table 88. Bright Biotech Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 89. Bright Biotech Molecular Pharming Product Offered
Table 90. Bright Biotech Main Business
Table 91. Bright Biotech Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Bright Biotech Latest Developments
Table 93. Core Biogenesis Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 94. Core Biogenesis Molecular Pharming Product Offered
Table 95. Core Biogenesis Main Business
Table 96. Core Biogenesis Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Core Biogenesis Latest Developments
Table 98. Diamante SRL Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 99. Diamante SRL Molecular Pharming Product Offered
Table 100. Diamante SRL Main Business
Table 101. Diamante SRL Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Diamante SRL Latest Developments
Table 103. Leaf Systems International Limited Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 104. Leaf Systems International Limited Molecular Pharming Product Offered
Table 105. Leaf Systems International Limited Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Leaf Systems International Limited Main Business
Table 107. Leaf Systems International Limited Latest Developments
Table 108. ORF Genetics Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 109. ORF Genetics Molecular Pharming Product Offered
Table 110. ORF Genetics Main Business
Table 111. ORF Genetics Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ORF Genetics Latest Developments
Table 113. Pfizer, Inc. Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 114. Pfizer, Inc. Molecular Pharming Product Offered
Table 115. Pfizer, Inc. Main Business
Table 116. Pfizer, Inc. Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Pfizer, Inc. Latest Developments
Table 118. ProdiGene Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 119. ProdiGene Inc Molecular Pharming Product Offered
Table 120. ProdiGene Inc Main Business
Table 121. ProdiGene Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. ProdiGene Inc Latest Developments
Table 123. Protalix Biotherapeutics, Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 124. Protalix Biotherapeutics, Inc Molecular Pharming Product Offered
Table 125. Protalix Biotherapeutics, Inc Main Business
Table 126. Protalix Biotherapeutics, Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Protalix Biotherapeutics, Inc Latest Developments
Table 128. Tiamat Sciences Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 129. Tiamat Sciences Molecular Pharming Product Offered
Table 130. Tiamat Sciences Main Business
Table 131. Tiamat Sciences Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Tiamat Sciences Latest Developments
Table 1. Molecular Pharming Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Gene Gun
Table 3. Major Players of Agroinfiltration
Table 4. Major Players of Electroporation
Table 5. Major Players of Agrobacterium-Mediated Gene Transfer
Table 6. Molecular Pharming Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 9. Molecular Pharming Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 12. Global Molecular Pharming Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Molecular Pharming Revenue Market Share by Player (2018-2023)
Table 14. Molecular Pharming Key Players Head office and Products Offered
Table 15. Molecular Pharming Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Pharming Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Molecular Pharming Market Size Market Share by Regions (2018-2023)
Table 20. Global Molecular Pharming Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Molecular Pharming Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Molecular Pharming Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Molecular Pharming Market Size Market Share by Country (2018-2023)
Table 24. Americas Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 26. Americas Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 28. APAC Molecular Pharming Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Molecular Pharming Market Size Market Share by Region (2018-2023)
Table 30. APAC Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 32. APAC Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 34. Europe Molecular Pharming Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Molecular Pharming Market Size Market Share by Country (2018-2023)
Table 36. Europe Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 38. Europe Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Molecular Pharming Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Molecular Pharming Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Molecular Pharming Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Molecular Pharming Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Molecular Pharming Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Molecular Pharming Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Molecular Pharming
Table 47. Key Market Challenges & Risks of Molecular Pharming
Table 48. Key Industry Trends of Molecular Pharming
Table 49. Global Molecular Pharming Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Molecular Pharming Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Molecular Pharming Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Molecular Pharming Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Medicago Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 54. Medicago Inc Molecular Pharming Product Offered
Table 55. Medicago Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Medicago Inc Main Business
Table 57. Medicago Inc Latest Developments
Table 58. Meristem Therapeutics S.A. (Ventria Bioscience) Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 59. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product Offered
Table 60. Meristem Therapeutics S.A. (Ventria Bioscience) Main Business
Table 61. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Meristem Therapeutics S.A. (Ventria Bioscience) Latest Developments
Table 63. Miruku Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 64. Miruku Molecular Pharming Product Offered
Table 65. Miruku Main Business
Table 66. Miruku Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Miruku Latest Developments
Table 68. Moolec Science Limited Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 69. Moolec Science Limited Molecular Pharming Product Offered
Table 70. Moolec Science Limited Main Business
Table 71. Moolec Science Limited Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Moolec Science Limited Latest Developments
Table 73. mozza Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 74. mozza Molecular Pharming Product Offered
Table 75. mozza Main Business
Table 76. mozza Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. mozza Latest Developments
Table 78. Nobell Foods Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 79. Nobell Foods Molecular Pharming Product Offered
Table 80. Nobell Foods Main Business
Table 81. Nobell Foods Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Nobell Foods Latest Developments
Table 83. Agrenvec S.L Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 84. Agrenvec S.L Molecular Pharming Product Offered
Table 85. Agrenvec S.L Main Business
Table 86. Agrenvec S.L Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Agrenvec S.L Latest Developments
Table 88. Bright Biotech Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 89. Bright Biotech Molecular Pharming Product Offered
Table 90. Bright Biotech Main Business
Table 91. Bright Biotech Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Bright Biotech Latest Developments
Table 93. Core Biogenesis Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 94. Core Biogenesis Molecular Pharming Product Offered
Table 95. Core Biogenesis Main Business
Table 96. Core Biogenesis Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Core Biogenesis Latest Developments
Table 98. Diamante SRL Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 99. Diamante SRL Molecular Pharming Product Offered
Table 100. Diamante SRL Main Business
Table 101. Diamante SRL Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Diamante SRL Latest Developments
Table 103. Leaf Systems International Limited Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 104. Leaf Systems International Limited Molecular Pharming Product Offered
Table 105. Leaf Systems International Limited Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Leaf Systems International Limited Main Business
Table 107. Leaf Systems International Limited Latest Developments
Table 108. ORF Genetics Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 109. ORF Genetics Molecular Pharming Product Offered
Table 110. ORF Genetics Main Business
Table 111. ORF Genetics Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ORF Genetics Latest Developments
Table 113. Pfizer, Inc. Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 114. Pfizer, Inc. Molecular Pharming Product Offered
Table 115. Pfizer, Inc. Main Business
Table 116. Pfizer, Inc. Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Pfizer, Inc. Latest Developments
Table 118. ProdiGene Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 119. ProdiGene Inc Molecular Pharming Product Offered
Table 120. ProdiGene Inc Main Business
Table 121. ProdiGene Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. ProdiGene Inc Latest Developments
Table 123. Protalix Biotherapeutics, Inc Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 124. Protalix Biotherapeutics, Inc Molecular Pharming Product Offered
Table 125. Protalix Biotherapeutics, Inc Main Business
Table 126. Protalix Biotherapeutics, Inc Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Protalix Biotherapeutics, Inc Latest Developments
Table 128. Tiamat Sciences Details, Company Type, Molecular Pharming Area Served and Its Competitors
Table 129. Tiamat Sciences Molecular Pharming Product Offered
Table 130. Tiamat Sciences Main Business
Table 131. Tiamat Sciences Molecular Pharming Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Tiamat Sciences Latest Developments
LIST OF FIGURES
Figure 1. Molecular Pharming Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Pharming Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Molecular Pharming Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Molecular Pharming Sales Market Share by Country/Region (2022)
Figure 8. Molecular Pharming Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Molecular Pharming Market Size Market Share by Type in 2022
Figure 10. Molecular Pharming in Recombinant Antibodies
Figure 11. Global Molecular Pharming Market: Recombinant Antibodies (2018-2023) & ($ Millions)
Figure 12. Molecular Pharming in Hormones, Vaccines
Figure 13. Global Molecular Pharming Market: Hormones, Vaccines (2018-2023) & ($ Millions)
Figure 14. Molecular Pharming in Industrial Enzymes
Figure 15. Global Molecular Pharming Market: Industrial Enzymes (2018-2023) & ($ Millions)
Figure 16. Molecular Pharming in Proteins & Protein-Based Materials
Figure 17. Global Molecular Pharming Market: Proteins & Protein-Based Materials (2018-2023) & ($ Millions)
Figure 18. Molecular Pharming in Technical Reagents
Figure 19. Global Molecular Pharming Market: Technical Reagents (2018-2023) & ($ Millions)
Figure 20. Molecular Pharming in Nutritional Products
Figure 21. Global Molecular Pharming Market: Nutritional Products (2018-2023) & ($ Millions)
Figure 22. Global Molecular Pharming Market Size Market Share by Application in 2022
Figure 23. Global Molecular Pharming Revenue Market Share by Player in 2022
Figure 24. Global Molecular Pharming Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 26. APAC Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 27. Europe Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 29. Americas Molecular Pharming Value Market Share by Country in 2022
Figure 30. United States Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Molecular Pharming Market Size Market Share by Region in 2022
Figure 35. APAC Molecular Pharming Market Size Market Share by Type in 2022
Figure 36. APAC Molecular Pharming Market Size Market Share by Application in 2022
Figure 37. China Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Molecular Pharming Market Size Market Share by Country in 2022
Figure 44. Europe Molecular Pharming Market Size Market Share by Type (2018-2023)
Figure 45. Europe Molecular Pharming Market Size Market Share by Application (2018-2023)
Figure 46. Germany Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Molecular Pharming Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Molecular Pharming Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Molecular Pharming Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 60. APAC Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 61. Europe Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 63. United States Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 64. Canada Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 67. China Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 68. Japan Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 69. Korea Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 71. India Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 72. Australia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 73. Germany Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 74. France Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 75. UK Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 76. Italy Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 77. Russia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 78. Spain Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 81. Israel Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 84. Global Molecular Pharming Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Molecular Pharming Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Molecular Pharming Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Pharming Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Molecular Pharming Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Molecular Pharming Sales Market Share by Country/Region (2022)
Figure 8. Molecular Pharming Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Molecular Pharming Market Size Market Share by Type in 2022
Figure 10. Molecular Pharming in Recombinant Antibodies
Figure 11. Global Molecular Pharming Market: Recombinant Antibodies (2018-2023) & ($ Millions)
Figure 12. Molecular Pharming in Hormones, Vaccines
Figure 13. Global Molecular Pharming Market: Hormones, Vaccines (2018-2023) & ($ Millions)
Figure 14. Molecular Pharming in Industrial Enzymes
Figure 15. Global Molecular Pharming Market: Industrial Enzymes (2018-2023) & ($ Millions)
Figure 16. Molecular Pharming in Proteins & Protein-Based Materials
Figure 17. Global Molecular Pharming Market: Proteins & Protein-Based Materials (2018-2023) & ($ Millions)
Figure 18. Molecular Pharming in Technical Reagents
Figure 19. Global Molecular Pharming Market: Technical Reagents (2018-2023) & ($ Millions)
Figure 20. Molecular Pharming in Nutritional Products
Figure 21. Global Molecular Pharming Market: Nutritional Products (2018-2023) & ($ Millions)
Figure 22. Global Molecular Pharming Market Size Market Share by Application in 2022
Figure 23. Global Molecular Pharming Revenue Market Share by Player in 2022
Figure 24. Global Molecular Pharming Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 26. APAC Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 27. Europe Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Molecular Pharming Market Size 2018-2023 ($ Millions)
Figure 29. Americas Molecular Pharming Value Market Share by Country in 2022
Figure 30. United States Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Molecular Pharming Market Size Market Share by Region in 2022
Figure 35. APAC Molecular Pharming Market Size Market Share by Type in 2022
Figure 36. APAC Molecular Pharming Market Size Market Share by Application in 2022
Figure 37. China Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Molecular Pharming Market Size Market Share by Country in 2022
Figure 44. Europe Molecular Pharming Market Size Market Share by Type (2018-2023)
Figure 45. Europe Molecular Pharming Market Size Market Share by Application (2018-2023)
Figure 46. Germany Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Molecular Pharming Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Molecular Pharming Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Molecular Pharming Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Molecular Pharming Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 60. APAC Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 61. Europe Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 63. United States Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 64. Canada Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 67. China Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 68. Japan Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 69. Korea Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 71. India Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 72. Australia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 73. Germany Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 74. France Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 75. UK Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 76. Italy Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 77. Russia Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 78. Spain Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 81. Israel Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Molecular Pharming Market Size 2024-2029 ($ Millions)
Figure 84. Global Molecular Pharming Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Molecular Pharming Market Size Market Share Forecast by Application (2024-2029)
